schneider said that he is hoping to conduct a subsequent study of 15 to 20 pregnancies and that he is encouraged by these results.
.
.
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.